CN Bio appoints Deepak Singh as Vice President of Sales and Marketing

CN Bio, a leading Organ-on-a-chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems (MPS), has today announced that is has appointed Deepak Singh as Vice President of Sales and Marketing. Deepak’s appointment supports the Company’s next phase of commercial development as it expands international operations, product research and development and sales in key global markets.

Bringing over 30 years of commercial experience within life sciences, Deepak’s appointment follows that of Dr Paul Brooks as CEO in December 20221, to drive CN Bio’s international scale-up operations for both the product and service sides of the business. This includes supporting the recent launch of the Company’s PhysioMimix® Single-organ Higher-Throughput (HT) System2, designed to overcome adoption barriers currently limiting the use of predictive human liver models within drug discovery workflows, enabling use within earlier stages where larger-scale comparative studies that investigate the efficacy, disposition or safety of lead candidate drugs are required.

Throughout his extensive career in the commercial life sciences sector, Deepak has provided leadership for high-performance sales and marketing teams to establish new technologies, from commercialisation through to global scale-up, as well as supporting expansion of existing products and services into the drug discovery, bioproduction, research and diagnostics markets. He joins CN Bio from PerkinElmer’s Horizon Discovery where he was Head of Global Commercial. Prior to this, Deepak was with Pacific Biosciences as Vice President of EMEA Operations. He also held senior-level sales and marketing positions at Affymetrix and the Genetic Analysis Unit of Applied Biosystems (formerly a PerkinElmer company). Deepak has a BSc in Biotechnology from the Polytechnic of Central London.

“Having had extensive experience within the life science industry, I am excited by the possibilities of OOC technology, and how fast the potential of this technology is being realised. As evidenced by the recent FDA Modernization Act 2.0 legislation in the US, this is a very promising time for the technology, and I am looking forward to joining the CN Bio team to bring their cutting-edge systems to more researchers across the globe, to enable decision-making within drug discovery workflows to be made with more confidence and earlier than ever before.” 

Deepak Singh, VP Sales and Marketing at CN Bio

Deepak’s business and leadership experience, alongside his life science background, is of huge value to CN Bio as we drive forward with the Company’s commercial excellence strategy and build our capabilities in 2023 and beyond. Following the successful launch of our PhysioMimix Single-organ HT System in February, Deepak joins us at an exciting time and will be pivotal for the international scale-up of the marketing and distribution of this new system and our existing portfolio of MPS products and services.” 

Dr Paul Brooks, CEO at CN Bio


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    CN-Bio. (2023, March 29). CN Bio appoints Deepak Singh as Vice President of Sales and Marketing. News-Medical. Retrieved on April 13, 2024 from

  • MLA

    CN-Bio. "CN Bio appoints Deepak Singh as Vice President of Sales and Marketing". News-Medical. 13 April 2024. <>.

  • Chicago

    CN-Bio. "CN Bio appoints Deepak Singh as Vice President of Sales and Marketing". News-Medical. (accessed April 13, 2024).

  • Harvard

    CN-Bio. 2023. CN Bio appoints Deepak Singh as Vice President of Sales and Marketing. News-Medical, viewed 13 April 2024,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
CN Bio and LifeNet Health LifeSciences partner to supply validated primary human cells for microphysiological systems